News

Today’s approval of Susvimo by the U.S. Food and Drug Administration is a watershed moment for all who are impacted by age-related macular degeneration (AMD), a leading cause of blindness among older adults.

Researchers are trying to identify specific changes in photoreceptor metabolism that contribute to AMD progression and may lead to new treatment approaches.

In this issue: President’s Corner, New Model Reveals Genetic Changes in Cell Aging Processes, Exercise and Alzheimer’s Disease, and more!

Read this interview with director of the National Eye Institute, Emily Chew, MD, on the role of diet and vitamins in macular degeneration.

Researchers have highlighted 11 genetic mutations that may predispose people to developing Alzheimer’s disease (AD) – including seven gene variants that have not been previously linked to AD.

Scientists have singled out a sequence of events preceding cell death associated with frontotemporal dementia and Alzheimer’s disease.